Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation

Patients Clinical Trial

— FONTANEX  

Official title:

Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04151004
• Other study ID #: FONTANEX_2019
• Status: Completed
• Phase: N/A
• Start date: November 4, 2019
• Est. completion date: June 1, 2022

Study information

• Verified date: October 2022
• Source: Swiss Federal Institute of Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Congenital heart disease (CHD) is the most common congenital defect, affecting about 1% of newborns. Among adults surviving complex CHD, the cohort of survivors after the Fontan palliation for univentricular physiology is the most rapidly growing. Given their unique physiology without a pumping chamber supporting the pulmonary circulation, their exercise capacity as adults is often severely reduced. Therefore, patients with grown-up CHD typically need long-term expert medical care causing constantly increasing healthcare- related costs. Specific exercise regimes might offer a safe, efficacious and cost-effective alternative to pharmacologic interventions and surgery. The underlying mechanisms of impaired exercise capacity in Fontan patients are, however, not fully understood and consequently, training regimes specifically tackling the limiting factors cannot be developed. In patients with CHD, studies have suggested that exercise limitations are secondary to the cardiac defects, factors related to cardiac surgery, chronotropic incompetence and underlying lung disease. Similar to heart failure patients, exercise limitations could be traced back to insufficient respiratory and leg muscle functions and impaired cardiovascular regeneration processes possibly due to an altered stem cell number and function in the peripheral blood.

The present study will investigate cardiac, respiratory and quadriceps muscle function at rest and during submaximal and maximal whole-body exercises. A special focus will be given on respiratory and quadriceps muscle strength, and proneness of these muscles to fatigue, which has not yet been objectively investigated. Moreover, different respiratory muscle training (RMT) protocols will be executed, to assess the safety of these interventions. Moreover, the current study will be the first to investigate the influence of exhaustive exercise protocols on the number and function of circulating stem and progenitor cells (CPCs) in Fontan patients. The number of these cell populations was shown to strongly correlate with long-term outcome and recovery in several diseases. This study aims to reveal whether Fontan patients show similarly alternated stem cell number and function in the peripheral blood, that likely result in impaired vascular regeneration processes and possibly also contribute to reduced exercise capacity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: June 1, 2022
• Est. primary completion date: June 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• Age: 18 - 55 years

• Fontan palliation (for Fontan patients)

• NYHA I - III (for Fontan patients)

• Willing to adhere to the study rules

Exclusion Criteria:

• NYHA IV (for Fontan patients)

• not being able to perform cycle exercise

• known diaphragmatic paresis

• being pregnant or breast feeding

• Intention to become pregnant during the course of the study

• known or suspected non-compliance, drug or alcohol abuse

• Regular intake of medication affecting sleep or the performance of the respiratory, cardiovascular or neuromuscular system (except for Fontan-related medication for patients)

• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

• previous enrolment in current study

• being investigator or his/her family member, employee or another dependent person

Related Conditions & MeSH terms

• Patients

Intervention

Other:
• Incremental cycling test (ICT)
Incremental cycling test to volitional exhaustion
• Constant load cycling test (CET)
Constant load cycling test to volitional exhaustion.
• Incremental respiratory muscle test (IncRMET)
Incremental respiratory muscle test to volitional exhaustion.
• Incremental quadriceps muscle test (IncQMT)
Incremental quadriceps muscle test to volitional exhaustion.
• Respiratory muscle training like interventions
Three different respiratory muscle training like interventions that are usually used for respiratory muscle trainings.

Locations

Country	Name	City	State
Switzerland	Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich	Zürich	ZH

Sponsors (1)

Lead Sponsor	Collaborator
Swiss Federal Institute of Technology

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in respiratory muscle strength (in cmH2O)	Change in respiratory muscle strength will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Primary	Change in quadriceps muscle strength (in Newton)	Change in quadriceps muscle strength will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in ventilation (in liter per minute)	Change in ventilation will be measured between baseline and after an acute exercise	On visit 1at baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in gas exchange (in liter per minute)	Change in gas exchange will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in heart rate (beats per minute)	Change in heart rate will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in cardiac output (in liter per minute)	Change in cardiac output will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in blood pressure (in mmHg)	Change in cardiac output will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)
Secondary	Change in blood oxygen saturation (in %)	Change in blood oxygen saturation will be measured between baseline and after an acute exercise	At baseline and after acute exercise (approximately 15 minutes)